AIM bulletins from ShareCast
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Pulsar Hekium reports another pressurised gas encounter
Tue 18 November 2025 15:02
(Sharecast News) - Pulsar Helium reported another pressurised gas encounter at its Topaz project in Minnesota on Tuesday, after the Jetstream 4 appraisal well intersected multiple gas-bearing zones and recorded a bottom-hole pressure of about 674 psi at 1
Nativo reports further progress at Bonanza
Tue 18 November 2025 14:58
(Sharecast News) - Nativo Resources reported further progress at its Bonanza gold mine in Peru on Tuesday, saying trenching, sampling and access rehabilitation work is advancing ahead of a planned restart of small-scale mining before the end of the year.
Oracle Power resumes drilling at Northern Zone gold project
Tue 18 November 2025 14:56
(Sharecast News) - Oracle Power said in an update on Tuesday that drilling had resumed at its Northern Zone gold project in Western Australia, as it started a second programme aimed at expanding the defined mineralisation ahead of planned mine development
Thor Explorations reports sharp rise in revenue, profit
Tue 18 November 2025 13:02
(Sharecast News) - Thor Explorations reported a sharp rise in third-quarter profit and revenue on Tuesday, as higher production at its Segilola mine in Nigeria, improved plant recoveries and a stronger gold price lifted financial performance.
Gear4music upgrades expectations again as first-half revenue jumps
Tue 18 November 2025 09:55
(Sharecast News) - Gear4music reported a sharp jump in first-half revenue and a return to profit on Tuesday, as the online musical instrument retailer continued to benefit from stronger market conditions and the early success of its revised growth strateg
Ixico secures £3.5m Huntington's disease contract
Mon 17 November 2025 15:59
(Sharecast News) - Ixico announced on Monday that it has secured a new £3.5m contract to provide imaging services for a global phase three clinical trial in Huntington's disease, marking a significant commercial win for the neuroscience-focused biomarker
Eden Research's Ecovelex gets another temporary approval in Italy
Mon 17 November 2025 15:42
(Sharecast News) - Eden Research said in an update on Monday that its bird-repellent maize seed treatment Ecovelex has received temporary approval in Italy for the 2026 growing season, ensuring farmers could continue to access it.